Distribution and characteristics of Escherichia coli clonal group A

James R. Johnson, Andrew C. Murray, Michael A. Kuskowski, Sören Schubert, Marie Francoise Prère, Bertrand Picard, Raul Colodner, Raul Raz, Sacared Bodison, Franklin R. Cockerill, Clovis Arns Da Cunha, Peter Echeverria, Sriluck Simasathien, Wim Gaastra, Lucinda M C Hall, Marina Klein, Hank A. Lockman, Imad Omer, Jane R. Schwebke, Guillem PratsRobert M. Rakita, Susan Rossman, Ronald B Schifman, Ronald Smith, Patricia L. Winokur

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim- sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.

Original languageEnglish (US)
Pages (from-to)141-145
Number of pages5
JournalEmerging Infectious Diseases
Volume11
Issue number1
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Sulfamethoxazole Drug Combination Trimethoprim
Virulence
Escherichia coli

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Johnson, J. R., Murray, A. C., Kuskowski, M. A., Schubert, S., Prère, M. F., Picard, B., ... Winokur, P. L. (2005). Distribution and characteristics of Escherichia coli clonal group A. Emerging Infectious Diseases, 11(1), 141-145.

Distribution and characteristics of Escherichia coli clonal group A. / Johnson, James R.; Murray, Andrew C.; Kuskowski, Michael A.; Schubert, Sören; Prère, Marie Francoise; Picard, Bertrand; Colodner, Raul; Raz, Raul; Bodison, Sacared; Cockerill, Franklin R.; Da Cunha, Clovis Arns; Echeverria, Peter; Simasathien, Sriluck; Gaastra, Wim; Hall, Lucinda M C; Klein, Marina; Lockman, Hank A.; Omer, Imad; Schwebke, Jane R.; Prats, Guillem; Rakita, Robert M.; Rossman, Susan; Schifman, Ronald B; Smith, Ronald; Winokur, Patricia L.

In: Emerging Infectious Diseases, Vol. 11, No. 1, 01.2005, p. 141-145.

Research output: Contribution to journalArticle

Johnson, JR, Murray, AC, Kuskowski, MA, Schubert, S, Prère, MF, Picard, B, Colodner, R, Raz, R, Bodison, S, Cockerill, FR, Da Cunha, CA, Echeverria, P, Simasathien, S, Gaastra, W, Hall, LMC, Klein, M, Lockman, HA, Omer, I, Schwebke, JR, Prats, G, Rakita, RM, Rossman, S, Schifman, RB, Smith, R & Winokur, PL 2005, 'Distribution and characteristics of Escherichia coli clonal group A', Emerging Infectious Diseases, vol. 11, no. 1, pp. 141-145.
Johnson JR, Murray AC, Kuskowski MA, Schubert S, Prère MF, Picard B et al. Distribution and characteristics of Escherichia coli clonal group A. Emerging Infectious Diseases. 2005 Jan;11(1):141-145.
Johnson, James R. ; Murray, Andrew C. ; Kuskowski, Michael A. ; Schubert, Sören ; Prère, Marie Francoise ; Picard, Bertrand ; Colodner, Raul ; Raz, Raul ; Bodison, Sacared ; Cockerill, Franklin R. ; Da Cunha, Clovis Arns ; Echeverria, Peter ; Simasathien, Sriluck ; Gaastra, Wim ; Hall, Lucinda M C ; Klein, Marina ; Lockman, Hank A. ; Omer, Imad ; Schwebke, Jane R. ; Prats, Guillem ; Rakita, Robert M. ; Rossman, Susan ; Schifman, Ronald B ; Smith, Ronald ; Winokur, Patricia L. / Distribution and characteristics of Escherichia coli clonal group A. In: Emerging Infectious Diseases. 2005 ; Vol. 11, No. 1. pp. 141-145.
@article{7bf0c6b6bafd46dba2406644ed9cd201,
title = "Distribution and characteristics of Escherichia coli clonal group A",
abstract = "Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9{\%} vs. 3{\%}; p < 0.001) and those resistant to trimethoprim- sulfamethoxazole (10{\%} vs. 1.7{\%}; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.",
author = "Johnson, {James R.} and Murray, {Andrew C.} and Kuskowski, {Michael A.} and S{\"o}ren Schubert and Pr{\`e}re, {Marie Francoise} and Bertrand Picard and Raul Colodner and Raul Raz and Sacared Bodison and Cockerill, {Franklin R.} and {Da Cunha}, {Clovis Arns} and Peter Echeverria and Sriluck Simasathien and Wim Gaastra and Hall, {Lucinda M C} and Marina Klein and Lockman, {Hank A.} and Imad Omer and Schwebke, {Jane R.} and Guillem Prats and Rakita, {Robert M.} and Susan Rossman and Schifman, {Ronald B} and Ronald Smith and Winokur, {Patricia L.}",
year = "2005",
month = "1",
language = "English (US)",
volume = "11",
pages = "141--145",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "1",

}

TY - JOUR

T1 - Distribution and characteristics of Escherichia coli clonal group A

AU - Johnson, James R.

AU - Murray, Andrew C.

AU - Kuskowski, Michael A.

AU - Schubert, Sören

AU - Prère, Marie Francoise

AU - Picard, Bertrand

AU - Colodner, Raul

AU - Raz, Raul

AU - Bodison, Sacared

AU - Cockerill, Franklin R.

AU - Da Cunha, Clovis Arns

AU - Echeverria, Peter

AU - Simasathien, Sriluck

AU - Gaastra, Wim

AU - Hall, Lucinda M C

AU - Klein, Marina

AU - Lockman, Hank A.

AU - Omer, Imad

AU - Schwebke, Jane R.

AU - Prats, Guillem

AU - Rakita, Robert M.

AU - Rossman, Susan

AU - Schifman, Ronald B

AU - Smith, Ronald

AU - Winokur, Patricia L.

PY - 2005/1

Y1 - 2005/1

N2 - Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim- sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.

AB - Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim- sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.

UR - http://www.scopus.com/inward/record.url?scp=19944427996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944427996&partnerID=8YFLogxK

M3 - Article

C2 - 15705341

AN - SCOPUS:19944427996

VL - 11

SP - 141

EP - 145

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 1

ER -